Sigma Ligands and IKK / NF - KB Inhibitors for Medical Treatment
The present invention relates to agents that act in concert with sigma receptor ligands to enhance their effectiveness in the treatment of cancer and inflammatory disease. It also relates to methods whereby agents can be identified that will be of use in combination with sigma ligands in the treatment of the aforesaid diseases.
WO 2,009,074,809 [MORE INFO
SPRUCE BARBARA [GB]; PERKINS NEIL [GB]; WATT STEPHEN [GB]
Type of Offer:
« More Medical Patents« More Diagnostic Patents